Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.03%
median of 851 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Bluejay Diagnostics, Inc.
Market Cap
$848052.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$843169.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
16.67%
Market Cap
$859749.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$862370.00
Gross Margin
N/A
TTM Avg
19.10%
3Y Avg
22.14%
5Y Avg
32.68%
Market Cap
$868085.00
Gross Margin
29.80%
TTM Avg
31.72%
3Y Avg
34.27%
5Y Avg
41.55%
Market Cap
$1.03M
Gross Margin
-1.87%
TTM Avg
-0.94%
3Y Avg
-0.47%
5Y Avg
-0.37%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bluejay Diagnostics, Inc. (BJDX) | $848052.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Decoy Therapeutics Inc. (DCOY)vs › | $843169.00 | 0.00% | 0.00% | 0.00% | 16.67% |
| Bone Biologics Corporation (BBLG)vs › | $859749.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $862370.00 | N/A | 19.10% | 22.14% | 32.68% |
| Ridgetech, Inc. (RDGT)vs › | $801835.00 | N/A | 3.40% | 12.49% | 15.69% |
| Sunshine Biopharma, Inc. (SBFM)vs › | $868085.00 | 29.80% | 31.72% | 34.27% | 41.55% |
| GlucoTrack, Inc. (GCTK)vs › | $892803.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| CDT Equity Inc. (CDT)vs › | $669763.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.03M | -1.87% | -0.94% | -0.47% | -0.37% |
| Clearmind Medicine Inc. (CMND)vs › | $1.06M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 19.64% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
